Muir Beach, CA, United States of America

Richard I Weiner

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard I Weiner. Retrieved from https://idiyas.com/inventor/richard-i-weiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard I Weiner: Innovator in Antiangiogenic Peptide Agents

Introduction

Richard I Weiner is an accomplished inventor based in Muir Beach, California. He has made significant contributions to the field of biotechnology, particularly in the development of antiangiogenic peptide agents. His work focuses on innovative solutions that have the potential to impact medical treatments.

Latest Patents

Richard I Weiner holds a patent for his invention titled "Antiangiogenic Peptide Agents." This patent encompasses novel antiangiogenic peptides that correspond to approximately 133 consecutive amino acids of the N-terminal sequence of growth hormone. This invention represents a significant advancement in the understanding and application of peptide agents in medical science.

Career Highlights

Weiner is affiliated with the University of California, where he continues to engage in research and development. His work at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Richard I Weiner's notable coworkers include Joseph A Martial and Ingrid Struman. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Richard I Weiner's contributions to the field of antiangiogenic peptides exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…